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Abstract
Inorganic polyphosphate (polyP) is a simple ancient polymer of linear chains of 
orthophosphate residues linked by high energy phospho-anhydride bonds ubiqui-
tously found in all organisms. Despite its structural simplicity, it plays diverse func-
tional roles. polyP is involved in myriad of processes including serving as microbial 
phosphagens, buffer against alkalis, Ca2+ storage, metal-chelating agents, pathogen 
virulence, cell viability and proliferation, structural component and chemical 
chaperones, and in the microbial stress response. In mammalian cells, polyP has 
been implicated in blood coagulation, inflammation, bone differentiation, cell 
bioenergetics, signal transduction, Ca2+-signaling, neuronal excitability, as a 
protein-stabilizing scaffold, and in wound healing, among others. This chapter will 
discuss (1) polyP metabolism and roles of polyP in prokaryotic and eukaryotic cells, 
(2) the contribution of polyP to survival, cell proliferation, and motility involved 
in wound healing in human skin keratinocytes, (3) the use of polyP-containing 
platelet-rich plasma (PRP) to promote wound healing in acute and chronic wounds, 
including burns, and (4) the use of polyP-containing PRP in excisional wound 
models to promote faster healing. While polyP shows promise as a therapeutic agent 
to accelerate healing for acute and chronic wounds, the molecular mechanisms as a 
potent modulator of the wound healing process remain to be elucidated.
Keywords: inorganic polyphosphate, wound healing, keratinocytes, platelet-rich 
plasma
1. Introduction
PolyP is a simple prebiotic molecule that varies in chain length between three 
and several thousand inorganic phosphates linked by phosphoanhydride bonds 
(Figure 1A). It is continuously synthesized from ATP or GTP and degraded by cel-
lular enzymes in bacteria [1–5] and eukaryotes, yet its pleiotropic functions remain 
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to be clarified. In bacteria, but not mammalian cells, the enzymes that catalyze 
these activities have been identified [6–10]. polyP is synthesized following osmotic, 
oxidative, UVB, or other cellular stresses, and augments bacterial survival [11–16]; 
four roles have been proposed: an energy source, chelation of metal ions, storage 
of phosphate and response to cellular stresses. Necessary for bacterial survival, 
polyP is implicated in essential biological processes in prokaryotes including stress 
response, motility, biofilm formation [17–22], virulence, sporulation, and quorum-
sensing [21–23]. Enzymes involved in polyP synthesis and degradation have been 
isolated and characterized in bacteria and other lower eukaryotes, and maintain 
tight control of polyP levels, as might be expected for a polymer controlling vital 
biological processes.
1.1 PolyP in prokaryotes
Drawing from the cellular ATP pool, bacterial polyphosphate kinase (PPK1) 
catalyzes the reversible transfer of the terminal γ-phosphate of ATP to polyP 
[24], whereas PPK2, expressed in other prokaryotes, transfers the terminal inor-
ganic phosphate (Pi) from polyP to GDP to form GTP [4, 25, 26]. In contrast, 
the exopolyphosphatase PPX1 hydrolyzes polyP into phosphate monomers, thus 
maintaining phosphate homeostasis [5]. PPK levels and activity are tightly regu-
lated, maintaining steady-state polyP concentrations in the bacterial cytosol at low 
micromolar levels, even in mutant strains deficient in PPX [27]. PolyP synthesis is 
Figure 1. 
(A) Schematic of linear structure of polyP, and its synthesis by polyphosphate kinase (PPK) and degradation 
by exopolyphosphatases (PPX1) or endopolyphosphatases (PPN). Constitutive (B and D) or Tet-inducible 
PPX1 (C and E) expression slows wound healing in cultured human keratinocytes (modified with permission 
from [33]).
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upregulated during nutrient deprivation [28, 29], or during osmotic [28], acidic pH 
[30], oxidative [31], or heat [32] stresses, potentially depleting cellular ATP pools 
by converting millimolar levels of ATP to long polyP chains (>1000 Pi) [31]. polyP 
levels are measured using enzyme-based assays that employ ppk to generate ATP 
from ADP, using luciferase as a reporter [33]. In another assay, cells are labeled with 
32Pi; polyP is isolated and hydrolyzed with PPX1, and thin-layer chromatography or 
phosphoimage analysis is performed [17]. Toluidine blue binding assays are effec-
tive for different chain-lengths but are relatively insensitive. Recently, a rapid and 
simple method has been described [34, 35].31P-NMR Spectroscopy is an effective 
and accurate method for measuring polyP in intact cells [36]. Electron ionization 
mass spectrometry [37], cryoelectron tomography and spectroscopy imaging [38] 
have also been employed. Protein affinity labeling in vivo uses the affinity of a 
recombinant polyP-binding domain of E. coli PPX1 (PPXbd) [39], which we and 
other investigators have used to specifically inhibit the function of polyP.
Not surprisingly, ppk mutants are extremely sensitive to environmental stresses 
[13, 31, 32, 40, 41], and exhibit reduced motility, virulence, and biofilm produc-
tion [42]. ppk gene expression is regulated by σ38, a transcriptional regulator for 
late stationary phase genes [43] and polyP, in turn, amplifies its own synthesis by 
inducing transcription of the gene encoding σ38 (RpoS) [29, 41, 42]. In response 
to oxidative or heat stress, polyP synthesis is regulated at a transcriptional and/or 
post-translational level, as PPK synthesis and levels are altered by antisense RNA 
that target ppk mRNA transcripts [44] as well as transient inactivation of PPX by 
stress-sensitive regulators that allow polyP levels to remain high until normal condi-
tions are restored [45].
1.2 PolyP in eukaryotes
While polyP is found in eukaryotes from protists to mammalian cells [11], the 
mechanism of polyP synthesis remains largely unknown for most eukaryotic organ-
isms [1, 45], except for S. cerevisiae, where the vacuolar transporter chaperone 4 
(VTC4) synthesizes polyP from ATP and then transports the polymer into vacu-
oles [46, 47]. Vacuolar polyP maintains phosphate homeostasis by appropriating 
phosphate during growth in phosphate-rich conditions [46], and releases phosphate 
during the cell cycle to provide precursors for DNA replication [48].
There is no sequence or structural homology between the polyP-synthesizing 
enzymes PPK1, PPK2, or VTC4, and homologues have yet to be found in higher 
eukaryotes [1]. While phylogenetic analysis of the prokaryotic branch reveals 
no clear homologues of E. coli PPK in a large number of polyP-synthesizing spe-
cies [49], a few enzymes have been identified that use polyP as phosphate donor 
in reactions that can be reversed in the presence of excess substrate in vitro [49, 
50]. In the absence of a polyP-synthesizing enzyme, polyP may be synthesized 
by the mitochondrial proton-motive force [51], in a complex process involving 
intact mitochondrial membranes [52]. Decreased polyP production resulting from 
depolarization of the mitochondrial membrane [52, 53] suggests that this may be a 
spontaneous process that does not need catalysis. Alternatively, inositol phosphates 
have also been implicated in polyP metabolism, since polyP levels are diminished in 
cells lacking the enzyme that synthesizes highly phosphorylated inositols [54–57]. 
Similar to polyP synthesis, polyP-degrading enzymes, such as yeast PPX1, have 
been found in lower eukaryotes, while mammalian polyP-specific degradation 
enzymes are mostly uncharacterized. However, h-prune, which regulates cell 
migration, also acts as a exopolyphosphatase for short-chain polyP in vitro [58, 59].
Subcellular fractionation, immunofluorescent staining, and biochemical quanti-
fication reveal that polyP is localized to the nucleus, cell membrane, cytoplasm, and 
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intracellular organelles in mammalian cells. It is specifically enriched in nucleoli, 
acidocalcisomes (organelles rich in protons, calcium (Ca2+), and phosphorus), and 
mitochondria [11, 60–63]. In the brain, astrocytes secrete polyP, which is taken up 
by neurons, indicating both intra- and extracellular localization [64, 65]. Similar to 
vesicular packaging of ATP, astrocytes release polyP via exocytosis from vesicular 
nucleotide transporter (VNUT)-containing vesicles [65]. A putative G protein-
coupled receptor in D. discoideum mediates cell surface binding of extracellular 
polyP, which as a signaling molecule, elicits differential effects on cell-substratum 
adhesion and cytoskeletal F-actin levels [66].
Eukaryotic polyP levels are in the 20–100 μM range (expressed as Pi concentra-
tion), with chain lengths ranging from 50 to 800 Pi residues (rat tissues) [67], 
averaging ~80 Pi residues in human platelets [68] to 200 Pi residues in yeast [67], 
compared to bacterial polyP, which can range up to thousands of Pi units long [53]; 
however, up to 130 mm medium-sized polyP chains are stored in dense granules in 
thrombocytes and mast cells [62, 68, 69]. Brain tissue exhibits among the highest 
polyP levels (~100 µm), which drop with age and neurodegenerative disease [11, 
70–72], consistent with the role of polyP in stabilizing protein unfolding intermedi-
ates as amyloid-like precursors [32]. High levels of polyphosphate are also found 
in osteoblast matrix vesicles, the initial sites of bone mineral formation [73]. PolyP 
concentrations and chain lengths are dynamic, and depend on growth conditions of 
cells; for example in Plasmodia, polyP has an average chain length of 100 Pi, which 
is degraded to 10 Pi during sporulation [67].
Studies on the myriad roles of polyP in higher eukaryotes have recently gained 
momentum. PolyP is directly or indirectly involved in diverse cell processes, 
including control of cell bioenergetics, signal transduction, activation of the 
mitochondrial permeability transition pore (mPTP), Ca2+-signaling [74, 75], and 
maintenance of the mitochondrial membrane potential [74]. Associated with mPTP 
[74] and voltage-gated channels, polyP regulates neuronal excitability [76] and 
astroglial signaling [64]. About 39% of intracellular polyP pools in astrocytes are in 
mitochondria [77], playing a role in bioenergetics [52, 77] and Ca2+-handling [74, 
78, 79]. As a signaling molecule, polyP released from astrocytes can mediate the 
physiological response to brain hypoxia [65].
In addition to its role as a gliotransmitter in the autonomic nervous system [64], 
the polymer also interacts with a variety of proteins, such as mammalian target of 
rapamycin (mTOR), fibroblast growth factor (FGF)-2, TRPM8, integrin β1, and 
glycosomal and ribosomal proteins and enzymes, consequently modulating cell 
survival and cell growth [80–86]. A fascinating finding of several recent studies is 
that polyP can covalently and non-enzymatically modify a small number of specific 
proteins in yeast [81] and humans containing lysine residues located in poly-acidic, 
serine, and lysine-rich (PASK) motifs, some of which are involved in ribosome 
biogenesis [87].
PolyP is involved in mTOR signaling, cell proliferation, and apoptosis [74, 
80], and stimulates the mTOR pathway [80] at concentrations normally found in 
mammalian cells (0.15–1.5 mM); [11], suggesting a role for the polymer in mam-
malian cell proliferation. By promoting release of translation initiation factor 
eIF4E, mTOR stimulates initiation of translation, particularly proteins involved in 
cell growth and proliferation. PolyP also enhances the mitogenic activity of FGF-2 
by promoting its binding to cell surface receptors [83]. PolyP appears to regulate 
apoptosis by inducing activation of caspase-3 in human plasma cells [88]. This 
polyanion also chelates metals, such as manganese and cadmium, blocking metal-
induced cell damage [89, 90].
Other roles for polyP in mammalian cells include coagulation via activation of 
blood clotting factor XII [69], inflammation [91] as well as Ca2+ chelation for bone 
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mineralization and osteogenic differentiation [92]. The polymer also contributes to 
pro-inflammatory responses upon release from mast cells [62]. Finally, serving as 
a stabilizing scaffold for protein-folding intermediates, polyP was recently shown 
to work as a protein-like chaperone protecting cells against stress-induced protein 
aggregation [93].
2.  The contribution of polyP to cell survival, proliferation, and motility 
involved in wound healing in skin keratinocytes
Inorganic polyP shows promise in different phases of wound healing, including 
hemostasis and re-epithelialization, as polyP is a normal component of different 
cells that play a role in this process, including platelets, dermal fibroblasts, and 
keratinocytes. The use of polyP as a therapeutic for acute and chronic wounding 
has begun to garner interest, in part because of experiments elucidating its role in 
wound healing [33], as well as in hemostasis [69, 94–99]. We have recently shown 
a role for polyP in the response to UV survival, cell motility, and wound healing 
[33]. Addition of exogenous polyP increased the rate of wound healing in standard 
scratch wound assays in vitro [33].
Whereas candidates for mammalian polyP metabolism have been shown to 
exhibit additional enzymatic activities [59], more specific polyphosphatases 
have been identified in lower eukaryotes including yeast, trypanosomes, and 
Dictyostelium. We therefore used exopolyphosphatase derived from S. cerevisiae 
(ScPPX1) to target intracellular polyP in human skin keratinocytes, an obvious 
choice for UV resistance, motility, and wound healing. The functions of polyP in the 
response of keratinocytes to UVB or wounding was studied by expressing ScPPX1, 
which selectively breaks down endogenous inorganic polyP, and not phosphopro-
teins, DNA, RNA, or nucleotide mono-, di-, or triphosphates [6]. Cells depleted of 
intracellular polyP by ScPPX1 expression exhibited increased sensitivity to UVB via 
enhanced apoptosis, and impaired wound healing [33]. Human keratinocytes stably 
expressing constitutive HisPPX1 or tetracycline (Tet)-inducible HisPPX1 were used 
to deplete cells of endogenous polyP, and study its role in wound healing assays 
performed on confluent monolayers, mimicking cell re-epithelialization during 
wound healing in vivo. RT-PCR and immunoblot analysis confirmed PPX1 expres-
sion in stable HisPPX1-expressing cells or in the presence of Tet (Figure 1B and C). 
Scratch gaps demonstrate marked attenuation of wound healing following constitu-
tive HisPPX1 or Tet-induced expression (Figure 1D and E).
Since keratinocyte proliferation and migration are crucial to re-epithelialization 
during wound healing, the contribution of polyP to cell growth and motility 
involved in wound healing was next determined. Vector control cells exhibited 
significantly higher rates of cell growth as well as BrdU incorporation into newly 
synthesized DNA in cells at the wound edge, compared with polyP-depleted 
HisPPX1-expressing cells (Figure 2). Further, real time monitoring and measure-
ment of cell motility performed in an xCelligence impedance-based system revealed 
significant decreases in cell motility in polyP-depleted keratinocytes (Figure 3). 
These results demonstrate that polyP depletion by either constitutive or inducible 
expression of PPX1 retards the rate of wound healing in human skin keratinocytes, 
by decreasing cell proliferation and motility. To determine if the loss of endogenous 
polyP can be supplemented with exogenous extracellular polyP, ScPPX1-expressing 
cells were grown in the presence of different concentrations of polyP, or with polyP-
rich platelet lysate (next section). Exogenously added polyP was found to accelerate 
wound healing in human keratinocytes in polyP dose-response experiments on 
confluent monolayers of keratinocytes subjected to scratch wound healing assays 
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Figure 3. 
Real-time monitoring and measurement of cell motility was performed in an xCelligence impedance-based 
system. Total number of cells attached to the bottom chamber were measured every 15 min over 24 hours, and 
are shown as technical duplicates, with assays repeated twice (left). Percentage of cell migration at the 24-hour 
time-point based on 100,000 cells plated at the top chamber (right; modified with permission from [33]).
Figure 2. 
Constitutive PPX1 expression decreases growth rate of keratinocytes. Viable cell counts were performed over 
11 days, and growth curves plotted for HisPPX1-expressing cells compared to vector cells (top). HisPPX1 and 
vector controls were subjected to scratch assays and proliferation was measured by in situ BrdU incorporation in 
cells at the wound edge (middle and bottom; modified with permission from [33]).
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(Figure 4). Interestingly, both intracellular and extracellular polyP dose-depend-
ently increased the rate of wound healing in vitro.
3.  The use of polyP-containing PRP to promote wound healing in acute 
and chronic wounds, including burns
Wound healing is a highly coordinated process involving biochemical and 
physiological interplay of keratinocytes and fibroblasts to restore skin integrity. 
Platelets are components of blood responsible for blood clotting and wound heal-
ing. Although the importance of platelets in wound healing has been extensively 
studied, the bioactive substance playing a major role in skin re-epithelialization 
during wound healing is still unclear. PRP has been shown to support the survival 
and proliferation of human keratinocytes [100], and is currently used as thera-
peutic for both acute and chronic wounds (for review see [101]). Discovery of the 
release of growth factors triggered an interest in using PRP for wound healing, and 
platelet lysates have been examined as a replacement for using fetal bovine serum in 
cell cultures, which may contain contaminants such as prions, or elicit an unwanted 
immune response in patients. Platelet-rich lysates derived from platelets are a 
by-product of blood preparation, and are thus inexpensive. Most studies focused on 
lysates for mesenchymal stromal cell culture for cell therapy, in which platelets are 
activated by thrombin and CaCl2, or by freeze-thaw.
In recent years, PRP has gained traction in many different specialties including in 
dermatology where it is used to treat acne [102], scarring [103], and alopecia [104, 105], 
in regenerative medicine where it is used to treat acute and chronic injuries to bone and 
cartilage [106, 107], in orthopedics and sports medicine where it is used to treat rotator 
cuff tears, osteoarthritis of the knee, hamstring injuries, and Achilles tendinopathy 
[108–110], in dentistry where it is used during tooth extractions, periodontal surgery, 
and dental implant surgery [111, 112], and more recently in wound healing to promote 
enhanced healing [113–118]. PRP is an autologous blood product generated from 
multiple rounds of centrifugation that serve to concentrate the number of platelets in 
plasma. PRP contains high concentrations of growth factors such as platelet-derived 
growth factor (PDGF), epidermal growth factor (EGF), and transforming growth fac-
tor beta (TGFβ) compared to plasma and whole blood [119, 120]. It also contains higher 
levels of pro- and anti-inflammatory cytokines that promote enhanced healing. Lastly, 
PRP is known to contain inorganic polyP which is continually synthesized from ATP or 
GTP, and is degraded by cellular enzymes in bacteria and eukaryotes.
The role of polyP secreted by platelets and present in PRP on cell proliferation 
and wound healing was investigated in human HaCaT keratinocytes co-transduced 
Figure 4. 
PolyP dose-dependently accelerates wound healing in cultured human keratinocyte, using polyP at 1 μM (left) 
or 10 μM (right; modified with permission from [33]).
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with either ScPPX1 or vector control, along with DsRed or GFP, respectively, as 
fluorescent markers in order to visualize and track cells that have reduced or normal 
levels of polyP. Cells stably expressing fluorescent-tagged DsRed-PPX1 or GFP-
empty vector were incubated with platelet lysate (4%) supplemented with or with-
out exogenous pure polyP (1 μM). In both vector-GFP control and polyP-depleted 
PPX1-DsRed cells treated with polyP, platelet lysate, or platelet lysate + polyP, cell 
growth curves revealed a significant increase in cell proliferation compared to 
untreated controls (data to be published elsewhere). PolyP quantification in platelet 
lysates using a micromolar polyP assay kit showed that a 4% platelet lysate contains 
~8 μM polyP, which was within the range used for exogenously added polyP. This 
assay measures increase in fluorescence intensity (emission 550 nm, excitation 
415 nm) of a PPD dye upon binding to polyP.
Cell migration/scratch assays were performed on PPX1-DsRed or vector-GFP 
control keratinocytes to assess the effects on wound healing and cell motility. 
Fluorescent pictures were taken at 10 min intervals for 36 hours using an EVOS 
FL time-lapse imaging system, and gap closure was quantified by Image J. In both 
GFP-vector cells and PPX1-expressing cells, the rate of wound closure in the scratch 
assays were significantly increased when cells were incubated either with platelet 
lysate alone, polyP alone, or both (data to be published elsewhere). These results 
together indicate that exogenous polyP, delivered either purified or from platelet-
enriched plasma, can accelerate wound healing.
To assess whether the increased rate of wound healing is attributable to polyP in 
platelet lysates, specific polyP inhibitors (polyP-binding protein PPXbd or UHRA-
9, a kind gift from Dr. James Morrissey) were utilized in wound healing assays. 
PPXbd, a recombinant polyP-binding domain of E. coli exopolyphosphatase, binds 
to platelet-derived polyP and blocks FXI activation, thrombin and fibrin genera-
tion, and consequently, inhibiting polyP procoagulant activity [99]. Interestingly, 
the enhanced rates of wound healing in vector control or polyP-depleted ScPPX-
expressing cells induced by supplementation with exogenous extracellular polyP 
from pure polyP or in platelet lysates, was completely reversed by addition of 
the polyP inhibitors PPXbd or UHRA-9 (data to be published elsewhere). PolyP 
secreted by platelets and present in platelet lysate or PRP may therefore play an 
essential role in re-epithelialization during wound healing.
3.1 Chronic wounds
The acceleration of wound healing is of paramount importance in the setting 
of acute and chronic wounds, as well as burn wounds. Open chronic wounds are a 
significant cause of additional morbidity in patient populations that already have a 
plethora of comorbidities [121]. Significant improvements in complete healing were 
reported in chronic wounds treated with PRP compared to no topical treatments in 
a 2011 systematic review and meta-analysis on the use of PRP in acute and chronic 
wounds [101]. Another review of PubMed and Cochrane databases found significant 
benefit of PRP for diabetic chronic wounds, specifically in wounds unresponsive to 
standard of care treatment options [113]. A third systematic review of nine random-
ized controlled clinical trials (RCT) suggested that well-designed high-powered 
RCTs are needed to demonstrate increased wound healing with PRP treatment [122].
Treatment of 56 patients with diabetic foot ulcers with twice weekly applications 
of PRP resulted in complete healing in 86% of patients in the treated groups vs. only 
68% in the control group [123]. Animal models using exosomes derived from PRP 
for full thickness skin wounds in a diabetic rat model also showed increased healing, 
as well as increased fibroblast proliferation and migration [124]. Platelet-rich fibrin 
also improved diabetic animal skin wound healing [125]. Overall, while there is no 
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consensus on this treatment modality in chronic wounds, it is becoming widely used, 
and many trials seek to understand its potential beneficial effects. Improvements in 
open wound area have been shown in a number of animal and clinical studies.
3.2 Acute wounds
Meta-analysis of rodent and non-rodent studies using a systematic review 
conducted under preferred reported items for systematic review of interventions 
(PRISMA) guidelines indicated that the treatment of wounds with PRP resulted in 
reduction of open wound area [126]. In addition to its role in wound healing, PRP 
reduced complications such as wound infection, exudate (mass of cells and fluid 
that seeps out of a wound), drainage, and hematoma formation [101]. PRP and PRP 
with keratinocyte and fibroblast cells were shown to increase re-epithelialization 
at 7–14 days post-injury in mouse models, compared to non-treated controls [127]. 
In full thickness porcine wounds treated with the secreted proteins of PRP, wound 
re-epithelialization and collagen deposition were significantly increased in treated 
animals vs. saline controls [128]. Thus, PRP may improve wound healing in acute 
surgical wounds by secreting growth factors that support local microenvironments 
that promotes healing [129]. PRP’s effectiveness has also been shown in bone grafting, 
cartilage regeneration, and non-cutaneous surgical procedures. The impact of PRP on 
normal and damaged (derived from chronic ulcers or irradiated) fibroblasts have been 
described [130]. In addition, despite the lack of reproducibility of platelet concentra-
tions due to differences in manufacturer-specific protocols for PRP preparation and 
differences in treatment methodologies, PRP has been shown to affect fibroblast 
proliferation and migration in a number of in vitro studies. As with chronic wounds, it 
is unclear why some studies, but not others, show a beneficial effect of PRP treatment.
3.3 Burns
PRP has been used as a topical treatment to accelerate wound healing in burn 
wounds, however, like in chronic and acute wounds, its use is still debated due to 
conflicting results [114]. Some papers recommend its use [115, 117, 118, 131–135], 
while others have shown non-significant changes in outcomes after treatment 
with PRP, and advise caution in using it in a wide-spread manner [114, 136–138]. 
A review of PRP for burns concluded that PRP may be useful in regeneration of 
dermal structures, increasing graft-take, and increasing re-epithelialization, but 
recommended further research on characterization of the mechanisms by which 
PRP can improve burn wound healing, donor site healing, and scar outcomes [139].
The use of side-by-side treatment of a split thickness skin graft (STSG) donor 
site with standard treatment or with PRP showed complete re-epithelialization in 
the PRP-treated side at day 11 vs. day 13 for the control. Histological samples taken 
from these healing wounds, and by H and E staining revealed increased epidermal 
thickness in PRP-treated wounds, as well as a significant increase in the number 
of blood vessels. After platelet concentrate in conjunction with STSG was used 
for deep burns, monitoring of viscoelastic properties of the resultant scars over 
12 months revealed that the skin’s return to normal viscoelastic properties was 
accelerated in burns treated with PRP compared to controls [133]. Compared to 
historic institutional standard of care controls, treatment of deep partial thick-
ness (DPT) burns using PRP applied with the autograft during skin grafting, pain 
scores, inflammation, pruritis (itchiness), cosmesis of the scar, and perfusion all 
showed improved outcomes [135].
Animal models of burn injury in rats treated with topical PRP or control showed 
that PRP treatment resulted in increased hydroxyproline, decreased inflammatory 
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cells infiltration, but no difference in fibroblast collagen production or angiogen-
esis [134]. In a rat animal model of DPT burns, PRP was effective in increasing % 
wound closure, but showed little effectiveness in the full thickness injury group. 
PRP treatment resulted in increased neo-epidermal thickness at day 21, as well 
as decreases in CD31, 68, and 163, TGFβ1, MMP2, and MPO+ cells indicating an 
increased resolution of inflammation [118]. PRP injection in burn wound scars 
in a rat animal model of burn injury also showed pain-associated markers to be 
decreased with treatment [132]. While positive healing was observed in most mod-
els, in a recent study using a swine model of burn, tangential excision, and grafting 
with or without PRP, PRP showed similar effect on re-epithelialization and scarring 
in full thickness wounds compared to control wounds [136].
In a randomized clinical trial from 2018, 27 patients with DPT burns that did not 
get autografted were treated with lyophilized PRP powder, and showed a signifi-
cant increased percent wound closure at 3 weeks in the treated group compared to 
control. Additionally, the infection rate in the PRP group was 26%, while 33% of 
control patients had postoperative infections [115]. PRP’s concentrated secretion 
of growth factors may include basic fibroblast growth factor, epidermal growth 
factor, platelet-derived growth factor (PDGF), insulin-like growth factor, trans-
forming growth factor β (TGFβ1), and vascular endothelial growth factor (VEGF) 
as probable mechanisms by which it can accelerate healing [139]. However, quan-
tification of growth factors TGFβ1, PDGF-AA, and VEGF in a cohort of five burn 
patients compared to five healthy volunteers showed comparable levels of growth 
factors in the PRP from burn patients and health volunteers. Thus, there may be an 
additional factor in PRP that is possibly altered in burn patients (or patients with 
other pathologies such as diabetes or other conditions that would lead them to have 
surgical procedures yielding acute wounds) that may contribute to its success in 
treating some wounds and failure in others. Due to the effect burns have on the 
pathophysiology of blood coagulopathy [140–142] and capillary endotheliopathy 
[143, 144] after injury, it is reasonable to assume that platelets from burn patients 
may have differing levels of polyP. Associating this data with what is known about 
polyP, its ubiquitous presence in all prokaryotic and eukaryotic organisms, and its 
role in the response to cellular stress, it was hypothesized that polyP may contribute 
to wound healing.
4.  PolyP and polyP-containing platelet rich plasma accelerates 
re-epithelialization in vitro and in vivo
A HaCaT keratinocyte polyP-depleted cell line and vector control was used in 
growth curves and scratch assays to evaluate polyP, platelet lysate, or combined 
treatment to accelerate wound healing in vitro. PolyP-containing PRP was also 
evaluated as a treatment in a splinted model of excisional wounding in vivo. 
Exogenous polyP was also spiked into PRP to assess its role. Treatment with 
the polyP-containing treatments increased cell growth and attenuated open 
wound area in vitro (p < 0.001). Addition of a polyP inhibitor abrogated these 
effects (p < 0.0001). PRP-treated wounds re-epithelialized faster compared 
to untreated wounds when analyzed at Days 3 and 5 (n = 6 wounds, p < 0.05). 
Re-epithelialization was further enhanced by exogenous polyP addition to PRP 
as evidenced by elongated epithelial tongues (Figure 5) in the low and high dose 
PRP + polyP treatment groups compared to PRP alone (n = 8 wounds, p < 0.05; 
data to be published elsewhere). Due to its autologous nature, PRP serves as a safe 
and efficacious option for accelerating wound healing, and may be enhanced by 
the exogenous addition of polyP.
11
Inorganic Polyphosphates Are Important for Cell Survival and Motility of Human Skin…
DOI: http://dx.doi.org/10.5772/intechopen.87183
4.1 PRP-treated wounds heal faster than controls in vivo
PRP was generated based on a previously published protocol [145]. Briefly, whole 
blood was collected, and centrifuged to create platelet-poor plasma (PPP) and a pellet 
of platelets. PPP was then removed and the platelets were resuspended and activated 
with thrombin and calcium chloride (CaCl2) to form a “biobandage”-like gel. Whole 
blood, packed RBCS, and PRP were stained with Wright and Giemsa stains to confirm 
PRP platelet concentration. A murine model of full thickness excisional wound heal-
ing was used where 6 mm punch biopsies were created on dorsal flanks of C57BL/6 
mice [146, 147]. Wounds were splinted to encourage healing by re-epithelialization 
as opposed to contracture. They were subsequently treated with PRP, or no treatment 
was applied. Tegaderm dressing was applied and kept in place for 3 days. Pictures 
were taken at days 3, 4, 5, 6, or 7. By day 7, wounds were mostly closed.
In a second experiment, wounded mice were divided into four treatment groups: 
untreated, PRP only, PRP + 10 μM polyP (low dose) and PRP + 100 μM polyP (high 
dose). Doses of polyP were calculated by examining historical data from the litera-
ture on platelet levels, as well as polyP concentrations in platelets. The mean platelet 
count for C57BL/6 mice is 9.85 ± 1.40 × 1011 platelets/L, however, because there are no 
reliable reports of polyP concentrations per platelet in mice, human platelet counts 
and polyP concentrations were extrapolated for this experiment [148]. Human plate-
let concentrations range from 1.5 to 4.5 × 1011 platelets/L [149]. It is also known that 
platelets contain 0.74 ± 0.08 μmol polyP/1 × 1011 platelets [150]. Therefore, whole 
blood should contain between 1 and 3 μM polyP, and PRP, which contains at least 
3-fold higher levels of platelets compared to whole blood, should contain 3–9 μM of 
polyP. We added ~10 μM in the low dose group, and a 10× concentration compared to 
the low dose group for the high dose group (100 μM). Lyophilized polyP was recon-
stituted in dH2O to 1 M. PolyP took up 10% of the total treatment volume of PRP.
Treatments were applied on Day 0, and Tegaderm™ dressings stayed in place 
through day 3. On day 3 and 4, dressings were removed, and pictures were taken. 
On day 5, dressings were removed, pictures were taken, and wounds were excised 
Figure 5. 
Untreated or treated wounds were excised on day 5 and fixed in formalin, paraffin embedded, sectioned, and 
stained with H&E. Sections were imaged, and composited to create an image with areas of normal skin on both 
sides with the epithelial tongue (orange arrow) protruding from each side of normal skin. The epithelial gap is 
demarcated by the black arrow where no epithelium is present. Scale bar = 200 μm. Representative histology of 
untreated (A), PRP only treated (B), PRP + 10 μM polyP-treated wounds are shown. Epithelial tongue length 
was measured with Image J and quantified.
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with underlying fascia and were sewn into histological cassettes to retain wound 
orientation. These samples were then paraffin embedded and H&E stained. 
Sections were imaged, and epithelial tongue length was measured using Image 
J. Epithelial tongues were defined as new epithelium if there was no uninjured 
dermis underneath the epithelium.
Compared to whole blood, PRP contained a higher concentration of platelets 
(data to be published elsewhere). The splinted wound model was used to shift the 
healing towards re-epithelialization instead of the normal contraction observed in 
mice. PRP application was easily applied as a “bio-bandage” gel-like liquid (data to 
be published elsewhere). The 6 mm punch biopsies allowed for the creation of simi-
lar wound size between animal groups at day 0 (0.33 cm2 ± 0.13 vs. 0.39 ± 0.15 cm2, 
p = n.s.; data to be published elsewhere). At days 3 (0.09 ± 0.06 vs. 0.23 ± 0.13) and 
5 (0.12 ± 0.07 vs. 0.25 ± 0.12) PRP-treated wounds had significantly smaller open 
wound areas compared to control animals (n = 6, p < 0.05). At days 6 and 7, this 
difference leveled off.
4.2 Exogenous spiking of PRP with polyP further accelerates healing in vivo
To further investigate the potential role of polyP in PRP, wounds were treated 
with PRP or with PRP with low or high dose-spiked polyP. Untreated wounds were 
largely open by day 5, while PRP treated wounds were smaller and contained newly 
formed epithelium (data to be published elsewhere). Spiking with low or high dose 
polyP further stimulated epithelialization, and wounds were smaller with increas-
ing doses. By histomorphometric analysis, epithelial tongues can be seen by H&E 
staining. In untreated wounds, these tongues are small and shallow. PRP treatment 
results in a more proliferative epithelium that is thicker and longer than untreated 
samples. Spiking with low and high dose polyP creates longer epithelial tongues). 
Epithelial tongue measurement by Image J shows a significant decrease in tongue 
length in untreated and PRP only treated vs. PRP + high dose polyP (737.38 ± 121.21 
and 925.55 ± 214.17 vs. 1186.91 ± 255.06 μM, n = 8, p < 0.0001, p < 0.05). PRP + high 
dose polyP-treated wounds also had significantly longer epithelial tongues com-
pared to PRP + low dose polyP (n = 8, p < 0.05). PRP contains polyP at a concentra-
tion near 5 μM. The exogenous addition of polyP to the PRP promoted keratinocyte 
growth and proliferation, as is evidence by the increased epithelial tongue length 
with increasing doses of polyP administration.
5. Conclusion
PolyP plays key roles in essential biological processes in bacteria, and its increas-
ing importance in eukaryotes is becoming apparent, including its participation 
in blood coagulation and wound healing. Recent advances in measurement and 
localization of polyP, along with our growing understanding of polyP metabolism 
and its interaction with specific proteins allows us to begin to analyze mechanisms 
responsible for cell-specific roles of polyP. Our ability to regulate polyP in eukary-
otic cells opens possibilities for therapeutic intervention. Future work related to 
wound healing should be aimed at investigating the specific roles of intra- and 
extracellular polyP in keratinocytes, as well as the potential importance of polyP in 
other skin cells, including dermal fibroblasts, as these cells make up the majority of 
the skin. As polyP is also secreted by activated platelets and is important for normal 
blood clotting, the application of polyP-containing PRP as a biologic dressing may 
positively contribute to wound healing. We have completed two clinical trials using 
platelet-rich plasma for wound healing, a phenomenon that may be explained by 
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the presence of polyP. PolyP levels and chain lengths should also be quantified in 
healthy and pathologic conditions in order to assess appropriate levels when treat-
ing acute or chronic wounds in the future.
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